Myriad Genetics
MYGN
MYGN
205 hedge funds and large institutions have $1.98B invested in Myriad Genetics in 2022 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 65 increasing their positions, 74 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
8% less capital invested
Capital invested by funds: $2.16B → $1.98B (-$175M)
12% less repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 74
Holders
205
Holding in Top 10
–
Calls
$7.18M
Puts
$811K
Top Buyers
| 1 | +$19.4M | |
| 2 | +$18.9M | |
| 3 | +$8.09M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$6.8M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$4.18M |
Top Sellers
| 1 | -$22.3M | |
| 2 | -$6.98M | |
| 3 | -$5.4M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
-$4.39M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$4.36M |